Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Michelson

Showing results (71-80 of 89) with videos related to

Pageof 9
Sort By:
Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine|July 12, 2016
Suvorexant in Patients with Insomnia: Pooled Analyses of Three-Month Data from Phase-3 Randomized Controlled Clinical TrialsW Joseph Herring, Kathleen M Connor, Ellen Snyder, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|April 22, 2017
Suvorexant in Elderly Patients with Insomnia: Pooled Analyses of Data from Phase III Randomized Controlled Clinical TrialsW Joseph Herring, Kathryn M Connor, Ellen Snyder, et al.
European Child & Adolescent Psychiatry|February 1, 2006
A comparison of North American versus non-North American ADHD study populationsJan K Buitelaar, Joanne Barton, Marina Danckaerts, et al.
Drug and Alcohol Dependence|April 12, 2008
Atomoxetine treatment of adults with ADHD and comorbid alcohol use disordersTimothy E Wilens, Lenard A Adler, Margaret D Weiss, et al.
The American Journal of Psychiatry|November 2, 2002
Once-daily atomoxetine treatment for children and adolescents with attention deficit hyperactivity disorder: a randomized, placebo-controlled studyDavid Michelson, Albert J Allen, Joan Busner, et al.
Headache|October 20, 2012
Long-term open-label safety study of rizatriptan acute treatment in pediatric migraineursDavid J Hewitt, Eric Pearlman, Mirja Hämäläinen, et al.
The New England Journal of Medicine|May 3, 2018
Randomized Trial of Verubecestat for Mild-to-Moderate Alzheimer's DiseaseMichael F Egan, James Kost, Pierre N Tariot, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|August 23, 2007
High-dose atomoxetine treatment of ADHD in youths with limited response to standard dosesChristopher J Kratochvil, David Michelson, Jeffrey H Newcorn, et al.
Journal of Neuromuscular Diseases|August 29, 2022
Real-world Adherence to Nusinersen in Adults with Spinal Muscular Atrophy in the US: A Multi-site Chart Review StudyLauren Elman, Bora Youn, Crystal M Proud, et al.
Pain Reports|October 30, 2023
A randomized, double-blind, placebo-controlled study of histone deacetylase type 6 inhibition for the treatment of painful diabetic peripheral neuropathyDavid Michelson, William W Chin, Robert H Dworkin, et al.
Pageof 9

Showing results (71-80 of 89) with videos related to

Sort By:
Pageof 9
Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine|July 12, 2016
Suvorexant in Patients with Insomnia: Pooled Analyses of Three-Month Data from Phase-3 Randomized Controlled Clinical TrialsW Joseph Herring, Kathleen M Connor, Ellen Snyder, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|April 22, 2017
Suvorexant in Elderly Patients with Insomnia: Pooled Analyses of Data from Phase III Randomized Controlled Clinical TrialsW Joseph Herring, Kathryn M Connor, Ellen Snyder, et al.
European Child & Adolescent Psychiatry|February 1, 2006
A comparison of North American versus non-North American ADHD study populationsJan K Buitelaar, Joanne Barton, Marina Danckaerts, et al.
Drug and Alcohol Dependence|April 12, 2008
Atomoxetine treatment of adults with ADHD and comorbid alcohol use disordersTimothy E Wilens, Lenard A Adler, Margaret D Weiss, et al.
The American Journal of Psychiatry|November 2, 2002
Once-daily atomoxetine treatment for children and adolescents with attention deficit hyperactivity disorder: a randomized, placebo-controlled studyDavid Michelson, Albert J Allen, Joan Busner, et al.
Headache|October 20, 2012
Long-term open-label safety study of rizatriptan acute treatment in pediatric migraineursDavid J Hewitt, Eric Pearlman, Mirja Hämäläinen, et al.
The New England Journal of Medicine|May 3, 2018
Randomized Trial of Verubecestat for Mild-to-Moderate Alzheimer's DiseaseMichael F Egan, James Kost, Pierre N Tariot, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|August 23, 2007
High-dose atomoxetine treatment of ADHD in youths with limited response to standard dosesChristopher J Kratochvil, David Michelson, Jeffrey H Newcorn, et al.
Journal of Neuromuscular Diseases|August 29, 2022
Real-world Adherence to Nusinersen in Adults with Spinal Muscular Atrophy in the US: A Multi-site Chart Review StudyLauren Elman, Bora Youn, Crystal M Proud, et al.
Pain Reports|October 30, 2023
A randomized, double-blind, placebo-controlled study of histone deacetylase type 6 inhibition for the treatment of painful diabetic peripheral neuropathyDavid Michelson, William W Chin, Robert H Dworkin, et al.
Pageof 9